Lv3
370 积分 2024-06-26 加入
Epidemiology of cardiovascular–kidney–metabolic syndrome
9小时前
待确认
Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats
26天前
已完结
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia
1个月前
已完结
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
3个月前
已关闭
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
3个月前
已完结
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
3个月前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
3个月前
已完结
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
3个月前
已完结
Triglycerides and cardiovascular disease
4个月前
已完结
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
4个月前
已完结
皖公网安备34019202002308
